A brief look at the latest scientific discoveries and advancements focused on cutting-edge research from peer-reviewed journals.
AI analysis of blood samples flags who is immune-ready before a shot.
read more
Extended organoid lifespans open new ways to study brain development and disease.
read more
Columbia Engineering researchers built a human tissue platform that captures how circulating cancer cells colonize distant organs
read more
New study shows that gladiolin can switch Candida albicans from its damaging, invasive form back into a harmless yeast state, pointing to new ways to ...
read more
Findings offer clues into how some people reach extreme old age while avoiding major disease.
read more
Advance that could make it easier for more hospitals to deliver this cancer therapy.
read more
Research team applies water freeze-drying to reduce preparation artifacts in scanning electron microscopy of bacteria
read more
Ohio State researchers build nanocarriers from red blood cell lipids that evade immune detection and target cancer cells in early studies
read more
Whitehead Institute researchers solve a long-standing mystery about why cells hold onto such large stores of these small molecules
read more
WashU researchers identify a molecular switch in the brain’s stress center that could point toward more targeted pain therapies
read more
Vanderbilt researchers develop a technique to recover intact whole cells from archived formalin-fixed tissue
read more
New photochemically driven technique reveals protein interactions unique to cancer cells
read more
New research finds Prevotella melaninogenica can survive oxygen exposure despite long being classified as incapable of tolerating it
read more
Cold Spring Harbor researchers address a long-standing obstacle in translating neuroscience findings from mice to humans
read more
Northwestern research finds AI use also nudges proposals toward safer, already-funded research directions
read more
Belgian researchers trace a widely cited 2023 finding to a software bug, though the debate over the data isn't settled
read more